Novo Nordisk, Covance Recognized with ACRP-Avoca Quality Awards
Pharma company Novo Nordisk and CRO Covance topped the list of winners of the Association of Clinical Research Professionals (ACRP) and the Avoca Group joint Quality Awards last week.
Finalists for the sponsor and CRO awards were selected based on responses to a survey of sites Avoca conducted in early 2020. Sites were asked to rate CROs and sponsors on a series of attributes related to quality outcomes, including partnership and communication skills, as well as quality of clinical trial design, execution and oversight.
Following Novo Nordisk in the sponsor category were GlaxoSmithKline in second place and AstraZeneca in third place. ICON and PRA Health Sciences were awarded second place and third place, respectively, in the CRO category.